These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Has lymphography a role in early stage testicular germ cell tumours? Stephenson NJ; Sandeman TF; McKenzie AF Australas Radiol; 1995 Feb; 39(1):54-7. PubMed ID: 7695529 [TBL] [Abstract][Full Text] [Related]
5. [Surgery of residual masses after chemotherapy in patients with testicular cancer]. Fléchon A; Rivoire M; Berger N Rev Prat; 2007 Feb; 57(4):389-98. PubMed ID: 17455741 [TBL] [Abstract][Full Text] [Related]
6. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors. Green DB; La Rosa FG; Craig PG; Khani F; Lam ET Korean J Radiol; 2021 Oct; 22(10):1650-1657. PubMed ID: 34402242 [TBL] [Abstract][Full Text] [Related]
8. Late relapse of testicular germ-cell tumours after radiotherapy. Lancet; 1985 Nov; 2(8464):1125. PubMed ID: 2865593 [No Abstract] [Full Text] [Related]
9. The role of CT scanning in the surveillance of testicular tumours. Nathan PD; Rustin GR Clin Oncol (R Coll Radiol); 2003 May; 15(3):121-2. PubMed ID: 12801048 [No Abstract] [Full Text] [Related]
10. Computed tomography in the staging of testicular neoplasms. Lee JK; McClennan BL; Stanley RJ; Sagel SS Radiology; 1979 Feb; 130(2):387-90. PubMed ID: 216053 [TBL] [Abstract][Full Text] [Related]
11. Late relapse of a non-seminomatous germ cell tumour from residual mature teratoma. Van den Brande J; Schrijvers D; Vroman P; Prove A; Van Schil P; Becquart D; Van Marck E; Van Oosterom AT Acta Clin Belg; 1998 Jun; 53(3):193-7. PubMed ID: 9701855 [TBL] [Abstract][Full Text] [Related]
12. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. Geldart TR; Gale J; McKendrick J; Kirby J; Mead G BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours. Napier MP; Naraghi A; Christmas TJ; Rustin GJ Br J Cancer; 2000 Nov; 83(10):1274-80. PubMed ID: 11044349 [TBL] [Abstract][Full Text] [Related]
14. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology. Nolan L; Wheater M; Kirby J; Simmonds P; Mead G BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393 [TBL] [Abstract][Full Text] [Related]
15. Current management of stage I testicular non-seminomatous germ cell tumours. Pectasides D; Pectasides E; Constantinidou A; Aravantinos G Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019 [TBL] [Abstract][Full Text] [Related]
16. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Stomper PC; Kalish LA; Garnick MB; Richie JP; Kantoff PW Radiology; 1991 Sep; 180(3):711-4. PubMed ID: 1651526 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET in the management of germ cell tumor. De Giorgi U; Pupi A; Fiorentini G; Rosti G; Marangolo M Ann Oncol; 2005 May; 16 Suppl 4():iv90-94. PubMed ID: 15923438 [TBL] [Abstract][Full Text] [Related]
19. Clinical study of six cases showing late relapse of germ cell tumors. Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S Int J Urol; 2005 Sep; 12(9):855-8. PubMed ID: 16201988 [TBL] [Abstract][Full Text] [Related]
20. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival. Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]